Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
Phase 4
Completed
- Conditions
- DepressionSchizophreniaSchizoaffective Disorder
- Registration Number
- NCT00034801
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
This is a research study comparing the safety and efficacy of two active study medications
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 378
Inclusion Criteria
- Male or female subjects 18-60 years of age
- Female subjects of childbearing potential must be using a medically accepted means of contraception
- Each subject must have a level of understanding sufficient to perform all tests and examinations required by the protocol
- Subjects must be considered reliable
Exclusion Criteria
- Treatment with a drug within the last 30 days that has not received regulatory approval at the time of study entry
- Female subjects who are either pregnant or nursing
- Uncorrected hypothyroidism or hyperthyroidism
- Narrow-angle glaucoma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method